SC

Shilpa Chintamani Inamdar

Director Director DIN 03125885
DIN 03125885 First appointment Jan 2011 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Shilpa Chintamani Inamdar

Data last updated:

Shilpa Chintamani Inamdar was a Director at Saiseva Biotech Private Limited (2011–2017) and Designated Partner at Ansicht Scidel Diagnostics And Therapeut Ics Llp (from 2017). The companies operate in Life Sciences.

DIN 03125885
Primary Designation Director
Industry Life Sciences
First Appointment 05 Jan 2011
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saiseva Biotech Private Limited U73100PN2011PTC138178
Director05 Jan 20112011₹5.2 Lakh (FY 2017)Active
Designated Partner09 Mar 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ansicht Scidel Diagnostics And Therapeut Ics Llp
Saiseva Biotech Private Limited
Premium access

Shareholding and investment profile for Shilpa Chintamani Inamdar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shilpa Chintamani Inamdar

Shilpa Chintamani Inamdar was first appointed on 05 Jan 2011 as Director at Saiseva Biotech Private Limited. The most recent appointment on record is 09 Mar 2017 at Ansicht Scidel Diagnostics And Therapeut Ics Llp.

Shilpa Chintamani Inamdar held 2 earlier board appointments: Saiseva Biotech Private Limited (Director, 05 Jan 2011 to 14 Jul 2017); Ansicht Scidel Diagnostics And Therapeut Ics Llp (Designated Partner, from 09 Mar 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available